Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Risk estimation, prior

The analyst cautioned that the risk estimates are uncertain by a factor of 4 or more, and later model iteration by ICRP and BEIR and adjustments to various parameters have modified those results somewhat (perhaps one-half of the prior risk) (28). Nevertheless, when one examines the huge uncertainties incumbent in risk calculations for organic chemicals, it is remarkable in this case that a true risk could be suggested to be within one order of magnitude of the calculated risk. [Pg.693]

To provide the most realistic representation of risk, all forms of uncertainty arc considered. Rather than assuming the existence of some representative condition prior to the accident scenario, a study models the full range of conditions and other uncertainties that can affect the scenario. Results include uncertainties in the frequency and consequences of each scenario. The upper uncertainty bound shown for the QRA risk estimates is a measure of the analysts confidence in the results. There is a 95 percent chance that the risk is less than the upper bound. [Pg.116]

Toxicity data (the SF and RfD) for As have been derived from toxicological studies performed using soluble forms of As. Therefore, site-specific bioavailability data obtained by in vitro or in vivo methods require conversion to relative bioavailability (RBA), as presented in the previous section, prior to its use in risk assessment. Bioavailability data can be used to provide more accurate exposure assessments that will result in more reasonable and site-specific risk estimates. Using RBA values, adjustments to toxicity values can be made as follows ... [Pg.131]

A summary of the key Lessons Learned taken from the Jime 2011 interim report is shown in the Fig. 15.6. These have been color-coded according to prior risk estimation , accident response , engineering design and offsite response . In addition, the four major technical issues described in the above section are grouped together at... [Pg.267]

WHITE - PRIOR RISK ESTIMATION ""AH6E - ACCIOeaT RESPONSE ALE BLUE -EHGINEERING DESIGN... [Pg.267]

Mosleh, Kazarians, and Gekler obtained a Bayesian estimate of the failure rate, Z, of a coolant recycle pump in llie hazard/risk study of a chemical plant. The estimate was based on evidence of no failures in 10 years of operation. Nuclear industry experience with pumps of similar types was used to establish tire prior distribution of Z. Tliis experience indicated tliat tire 5 and 95 percentiles of lire failure rate distribution developed for tliis category were 2.0 x 10" per hour (about one failure per 57 years of operation) and 98.3 x 10 per hour (about one failure per year). Extensive experience in other industries suggested the use of a log-nonnal distribution witli tlie 5 and 95 percentile values as llie prior distribution of Z, tlie failure rate of the coolant recycle pump. [Pg.614]

The degree of confidence in the final estimation of risk depends on variability, uncertainty, and assumptions identified in all previous steps. The nature of the information available for risk characterization and the associated uncertainties can vary widely, and no single approach is suitable for all hazard and exposure scenarios. In cases in which risk characterization is concluded before human exposure occurs, for example, with food additives that require prior approval, both hazard identification and hazard characterization are largely dependent on animal experiments. And exposure is a theoretical estimate based on predicted uses or residue levels. In contrast, in cases of prior human exposure, hazard identification and hazard characterization may be based on studies in humans and exposure assessment can be based on real-life, actual intake measurements. The influence of estimates and assumptions can be evaluated by using sensitivity and uncertainty analyses. - Risk assessment procedures differ in a range of possible options from relatively unso-... [Pg.571]

Friedman [12] introduced a Bayesian approach the Bayes equation is given in Chapter 16. In the present context, a Bayesian approach can be described as finding a classification rule that minimizes the risk of misclassification, given the prior probabilities of belonging to a given class. These prior probabilities are estimated from the fraction of each class in the pooled sample ... [Pg.221]

Myocardial toxicity, manifested in its most severe form by potentially fatal CHF, may occur either during therapy with mitoxantrone or months to years after termination of therapy. Mitoxantrone use has been associated with cardiotoxicity this risk increases with cumulative dose. In cancer patients, the risk of symptomatic CHF was estimated to be 2.6% for patients receiving up to a cumulative dose of 140 mg/m. For this reason, monitor patients for evidence of cardiac toxicity and question them about symptoms of heart failure prior to initiation of treatment. Monitor patients with multiple sclerosis (MS) who reach a cumulative dose of 100 mg/m for evidence of cardiac toxicity prior to each subsequent dose. Ordinarily, patients with MS should not receive a cumulative dose greater than 140 mg/m. Active or dormant cardiovascular disease, prior or concomitant radiotherapy to the mediastinal/pericardial area, previous therapy with other anthracyclines or anthracenediones, or concomitant use of other cardiotoxic drugs may increase the risk of cardiac toxicity. Cardiac toxicity with mitoxantrone may occur at lower cumulative doses whether or not cardiac risk factors are present (see Warnings and Administration.and.Dosage). [Pg.2021]

Empirical Bayes methodology and other kinds of shrinkage estimation may be considered in situations where there is some, perhaps limited information for a situation of specific interest, but also a desire to give some weight to data from situations less representative. The term shrinkage expresses the idea that an estimate from the situation of specific interest is shrunk toward some prior estimate such as an estimate from less strictly representative situations. As yet the methods have seen little or no use for pesticide ecological risk assessment in regulatory contexts. [Pg.36]

In a regular application of Bayes s rule, a prior estimate of probability and a likelihood function are combined to produce a posterior estimate of probability, which may then be used as an input in a risk analysis. Bayes s rule is... [Pg.93]

Bayesian methods are very amenable to applying diverse types of information. An example provided during the workshop involved Monte Carlo predictions of pesticide disappearance from a water body based on laboratory-derived rate constants. Field data for a particular time after application was used to adjust or update the priors of the Monte Carlo simulation results for that day. The field data and laboratory data were included in the analysis to produce a posterior estimate of predicted concentrations through time. Bayesian methods also allow subjective weight of evidence and objective evidence to be combined in producing an informed statement of risk. [Pg.171]

In December 1997, Secretary of Defense William Cohen announced a departmentwide anthrax immunization program for high-risk military personnel. Implementation began in March 1998. On May 18, 1998, the Secretary authorized the vaccination of all military forces (Cohen, 1998). Almost 2.5 million troop-equivalent doses of vaccine were required to implement the Secretary s decision, much more than had ever been produced by the licensed manufacturer in its entire history. Prior to Desert Storm, the primary vaccine users had been veterinary, laboratory, and industrial workers at risk of infection, for whom an estimated 60,000 doses of Anthrax Vaccine Absorbed (AVA) were distributed between 1974 and 1989, an average of 4,533 doses per year (foellenbeck et al., 2002). During Desert Storm, approximately 150,000 troops received 300,000 doses of AVA, without accurate recording of recipients or adverse reactions. [Pg.46]

One-fourth to one-half of all completed suicides were by psychiatric patients who had a history of a prior attempt. Thus, the majority of those who attempted suicide did not ultimately go on to complete the act, with estimates placing the ratio of attempters to completers at approximately 8 1. The absence of past suicide attempts does not guarantee or substantially reduce the risk of suicide if other risk factors are present. This risk factor is counterintuitive and, therefore, deserves special mention. Most individuals who die of suicide do so on their first or second attempt. Thus, the absence of a prior attempt should not minimize concern about its risk. In fact, the absence of previous attempts in a first-time, profoundly depressed middle-or late-life patient who has other risk factors (as discussed) should increase rather than diminish concern. Because suicide completions usually occur on the first or second attempt, multiple attempters (i.e., greater than five) are at greater risk for future attempts rather than completion. [Pg.108]

Although the lower limit of quantitation is established during assay validation and prior to microdosing, assay sensitivity remains an uncertainty until the actual analysis of the microdose samples as well. There is always the danger that plasma exposures from the microdose are lower than predicted and as a result plasma concentrations from some or all of the time points cannot be detected by the LC-MS/MS method. Reduction of this risk is achieved by collaborative communication between the bioanalytical chemist and the project team. Conservative estimates on bioavailability and clearance can be used to establish the necessary limit of detection needed to determine plasma concentrations for all time points. Updates on the progress of the assay development allow the team to decide if the achievable limit of detection will enable the determination of plasma concentrations from enough time points to make a go-no go decision. Of course, sensitivity is not an issue with AMS, which practically ensures that plasma concentrations will be determined, possibly for several days, enabling the observation of complex PK and clearance from deep compartments. [Pg.116]

At the present time, most US pesticide tolerances were established prior to the passage of FQPA. In assessing consumer risk from exposure to pesticides, the EPA first estimates consumer exposure. The maximum legal exposure to the pesticide is usually first calculated by assuming that... [Pg.303]

A risk-based waste classification system must focus on the inherent characteristics of waste, representative facilities, and generic events, because the system necessarily presumes that specific disposal sites and related waste treatment and disposal technologies have not yet been identified and characterized. NCRP emphasizes that the principles, framework, and implementation details of a risk-based waste classification system do not provide a substitute for site-specific risk assessments. The two most important cases where site-specific risk must be estimated are (1) an assessment of risk for the spectrum of actual wastes at a specific disposal site for the purpose of establishing site-specific waste acceptance criteria, and (2) an assessment of risk posed by a prior waste disposal at a site for the purpose of determining whether the risk is unacceptable and, thus, whether remedial action is required at the site. [Pg.69]

One technique employed to arrive, at an appropriate value has been postulated by L. Torbeck [16], who has taken a statistical and practical approach that in the absence of any other retest rationale can be judged as a technically sound plan. According to Torbeck, the question to be answered— how big should the sample be —is not easily resolved. One answer is that we first need a prior estimate of the inherent variability, the variance, under the same conditions to be used in the investigation. What is needed is an estimate of a risk level (defined as the percentage of probability that a significant difference exists between samples when there is none what statisticians call a type 1 error), the (i risk level ([1 is the probability of concluding that there is no difference between two means when there is one also known as a type 2 error) and the size of the difference (between the OOS result and the limit value) to be detected. The formula for the sample size for a difference from the mean is expressed as ... [Pg.410]


See other pages where Risk estimation, prior is mentioned: [Pg.582]    [Pg.635]    [Pg.582]    [Pg.575]    [Pg.1173]    [Pg.48]    [Pg.226]    [Pg.173]    [Pg.604]    [Pg.562]    [Pg.110]    [Pg.1293]    [Pg.485]    [Pg.855]    [Pg.54]    [Pg.118]    [Pg.347]    [Pg.678]    [Pg.732]    [Pg.337]    [Pg.43]    [Pg.244]    [Pg.308]    [Pg.327]    [Pg.3]    [Pg.197]    [Pg.63]    [Pg.201]    [Pg.134]    [Pg.16]    [Pg.73]    [Pg.845]   
See also in sourсe #XX -- [ Pg.267 ]




SEARCH



Prior

Risk estimation

Risks estimating

© 2024 chempedia.info